Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $228 | In Stock | |
5 mg | $589 | In Stock | |
10 mg | $959 | In Stock | |
25 mg | $1,420 | In Stock | |
50 mg | $1,920 | In Stock |
Description | Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors. |
In vivo | Rosmantuzumab (25 mg/kg; intraperitoneal injection; once a week; for 4 weeks) significantly protects animals from developing liver fibrosis[1]. Rosmantuzumab (25 mg/kg; intraperitoneal injection; once every two weeks; for 6 weeks) in a bleomycin-induced pulmonary fibrosis mouse model significantly inhibits skin thickness, collagen deposition, and the number of α-SMA-positive cells[1]. |
Alias | OMP-131R10 |
Molecular Weight | 150 kDa |
Cas No. | 1684393-04-1 |
Relative Density. | no data available |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.